Tekla Life Sciences Investors (HQL) — Cash Flow Reinvestment Rate

Latest as of March 2015: 0.00x

Tekla Life Sciences Investors (HQL) has a Cash Flow Reinvestment Rate of 0.00x as of March 2015, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $45.81K. See Tekla Life Sciences Investors (HQL) balance sheet quality index to measure how much of total assets are equity-financed.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$45.81K
USD

Capital Expenditures

$0.00
USD

Tekla Life Sciences Investors Cash Flow Reinvestment Rate (2008–2013)

Historical reinvestment intensity for Tekla Life Sciences Investors across 6 annual periods. Also explore balance sheet size of Tekla Life Sciences Investors for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Tekla Life Sciences Investors (2008–2013)

Year-by-year capital reinvestment analysis for Tekla Life Sciences Investors. For live market cap and broader valuation context, see HQL company net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2013 0.00x $0.00 $9.47K $0.00
2012 0.00x $0.00 $21.11 Million $0.00
2011 0.00x $0.00 $118.30 Million $0.00
2010 0.00x $0.00 $1.90 Million $0.00
2009 0.00x $0.00 $13.00 Million $0.00
2008 0.00x $0.00 $11.80 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow